| Purpose:Through clinical observation of the clinical effect and its effect on gastric function,the pathogenesis and pathogenesis regularity of chronic atrophic gastritis are further explored,so as to provide reference for the improvement of clinical pathway and clinical efficacy evaluation.Method:From January 2022 to January 2023,60 patients meeting the diagnostic standards of chronic atrophic gastritis were selected from the outpatient and inpatient department of Gastroenterology in Mongolian Medicine Affiliated Hospital of Inner Mongolia University for Nationalities.They were given 3g warm boiled water after breakfast,3g warm boiled water after lunch,3G warm boiled water after lunch,and 3G warm boiled water after dinner.Zhuangxi-21,3g(15 capsules)warm boiled water to take,during the medication according to the requirements of attention to diet,daily life.The total course of treatment was 21 days.Before treatment,during 7 days(telephone interview),14 days(telephone interview),and 21 days after treatment,60 patients received Mongolian medicine treatment of chronic atrophic gastritis after the disease symptoms,gastric function changes and clinical efficacy observation and comparison.Results:1.60 patients met the criteria.Before receiving treatment,we collected their information and collected their general status,age,gender,living habits and other characteristics.2.After treatment,46 patients showed significant improvement,9 patients improved and 5patients did not respond.The overall effective rate was 91.7%,P=0.000 < 0.05.As can be seen from Table 1,Chi-square test was used to study the difference between the total curative effect before and after treatment,and it was concluded that there was a significant difference between the total curative effect before and after treatment p=0.000<0.05,the total effective rate after treatment reached 91.7%.3.After 7 days of treatment,the main symptoms of the patient,such as stomach fullness,upper abdominal pain,loss of appetite,and other symptoms,did not improve significantly,P>0.05,indicating no statistical significance;The symptoms such as acid regurgitation and belching were significantly improved,and the P value(p<0.05)was significantly different.Minor symptoms,such as nausea or vomiting,dryness,tenderness in the upper abdomen and other symptoms had no significant improvement(p >0.05),indicating no significant difference,but fatigue,dry mouth,pale face and other symptoms improved,P <0.05 had significant difference.4.After 14 days of treatment,the main symptoms of the patient,such as upper abdominal pain,loss of appetite and weight loss,did not improve significantly(P>0.05),indicating no statistical significance;However,the main symptoms,such as fullness of stomach,acid regurgitation and belching,were significantly improved(P < 0.05).In addition,the minor symptoms,such as fatigue,nausea or vomiting,dry mouth,dryness,upper abdominal tenderness,pale face and other symptoms,also improved to varying degrees(P < 0.05),there were also significant differences.5.After 21 days of treatment,the main symptoms were improved,such as stomach fullness,upper abdominal pain,loss of appetite,weight loss,belching and acid regurgitation were significantly improved(P<0.05).Minor symptoms such as fatigue,nausea or vomiting,dry mouth,dryness,tenderness in the upper abdomen,and pallor were also significantly improved(p<0.05).These results were statistically significant,indicating a significant difference after 21 days of treatment.6.Comparison of gastric function before and after treatment was conducted by T-test,and the results showed that there was statistical significance(p < 0.05).There was no significant difference between PGR and before and after treatment(p > 0.05).There were significant differences in PGI,PGII and G-17(p < 0.05),and gastric function values were significantly improved.Conclusion:1.Due to the change of the causes and causes of the disease,one of the gastric digestive elements,is one of the main reasons for the increasing number of gastric failure,mainly Batakan and Sheila.Secondly,the indiscriminate use of drugs and people suffer from gastric diseases is not timely systematic treatment and chronic atrophic gastritis in clinical increasing.2.According to the characteristics of the disease and the increasing characteristics of disease and disease aggregation,activity,calm rule and to dispel baddry,shila,stomach function,protect the stomach mucosa treatment is the premise of dialectical medicine give a day eight taste powder(a day-badama),clear liver 27 taste pills(qin that stick),xi-21 after the curative effect of chronic atrophic gastritis,the stomach full,digestive function,upper abdominal pain,loss of appetite has improved significantly.3.The index of gastric function was significantly improved after the treatment of chronic atrophic gastritis by Mongolian medicine,and the research results on the influence of gastric function were relatively satisfactory. |
PDF Full Text Request